PEG10
PEG10 (paternally expressed 10) is a retrotransposon-derived protein that binds its own mRNA and self-assembles into virion-like capsids. It is also known as KIAA1051, HB-1, MEF3L, RGAG3, Mar2, Mart2, SIRH1 and RTL2. Browse Assay Genie's current range of PEG10 research reagents below, or read on for the biology behind the target.
PEG10 binds its own mRNA and self-assembles into virion-like capsids. These form virion-like extracellular vesicles that encapsulate the PEG10 mRNA and are released from cells, enabling intercellular transfer of that mRNA. The protein binds its own transcript in the 5'-UTR, near the boundary between the nucleocapsid and protease coding sequences, and at the start of the 3'-UTR. UniProt also notes that PEG10 may bind a 5'-GCCTGTCTTT-3' sequence in the myelin basic protein promoter, although further evidence is needed to confirm this.
The PEG10 gene is a paternally expressed imprinted gene thought to derive from the Ty3/Gypsy family of retrotransposons. It contains two overlapping open reading frames, RF1 and RF2. RF1 encodes a shorter gag-like protein with a CCHC-type zinc finger domain. A longer gag/pol-like fusion protein, which carries an additional aspartic protease motif, is produced by -1 translational frameshifting. This was the first example of -1 frameshifting in a eukaryotic cellular gene. The gene is highly conserved across mammals and retains the heptanucleotide (GGGAAAC) and pseudoknot elements needed for frameshifting. Additional isoforms arise from alternative splicing and from use of an upstream non-AUG (CUG) start codon.
PEG10 is expressed in adult and embryonic tissues, most notably placenta, and has been linked to cell proliferation, differentiation and apoptosis. It is required for trophoblast stem cell differentiation and acts at the immediate early stage of adipocyte differentiation. Knockout mice lacking the gene show early embryonic lethality with placental defects. PEG10 is overexpressed in many cancers, including hepatocellular carcinoma and B-cell lymphocytic leukaemia. It promotes proliferation by driving cell cycle progression from G0/G1, and may inhibit TGF-beta signalling, possibly through interaction with the TGF-beta receptor ACVRL1.
PEG10 is required for trophoblast stem cell differentiation, and knockout mice show early embryonic lethality with placental defects.
PEG10 is overexpressed in many cancers, including hepatocellular carcinoma and B-cell lymphocytic leukaemia, and enhances tumour progression.
PEG10 forms virion-like vesicles that encapsulate its own mRNA, enabling intercellular transfer of the transcript.
PEG10 is a paternally expressed imprinted gene derived from Ty3/Gypsy retrotransposons that uses -1 translational frameshifting.
PEG10 binds its own mRNA and self-assembles into virion-like capsids and extracellular vesicles that transfer the mRNA between cells. It is required for trophoblast stem cell differentiation, acts early in adipocyte differentiation, and in cancer promotes proliferation by driving cell cycle progression from G0/G1.
PEG10 (paternally expressed 10) is also called KIAA1051, HB-1, MEF3L, RGAG3, Mar2, Mart2, SIRH1 and RTL2. The gene yields a shorter gag-like protein and a longer gag/pol-like protein through -1 frameshifting. Alternative splicing and a CUG start codon give further isoforms.
The PEG10 gene is highly conserved across mammals, and the mouse ortholog is Peg10. Mouse knockouts die early in embryonic development with placental defects. Overexpression is associated with malignancies such as hepatocellular carcinoma and B-cell lymphocytic leukaemia. Check the datasheet of any product for its validated reactivity.
Pathway partners and related proteins named in PEG10 biology, including the TGF-beta receptor ACVRL1 and myelin basic protein.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q86TG7; product specifications from Assay Genie datasheets.